Natalja Eigėlienė
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- Advanced Breast Cancer Therapies
- Lung Cancer Treatments and Mutations
Papers in
-
- Cancer Genomics and Diagnostics 2
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Antti Pekka Jekunen (9 shared papers)Jatta Saarenheimo (7 shared papers)Heidi Andersén (4 shared papers)Marja Annika Tiirola (1 shared paper)Pirkko L. Härkönen (2 shared papers)Gajja Sophi Salomons (1 shared paper)Raymon Vijzelaar (1 shared paper)André B. P. Kuilenburg (1 shared paper)
In The Last Decade
Natalja Eigėlienė
12 papers receiving 420 citations
Natalja Eigėlienė's Hit Papers
Peers
Comparison fields: 5 of 43
- Cancer Research 185
- Pulmonary and Respiratory Medicine 165
- Oncology 39
- Pharmacology 14
- Radiology, Nuclear Medicine and Imaging 22
Countries citing papers authored by Natalja Eigėlienė
This map shows the geographic impact of Natalja Eigėlienė's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalja Eigėlienė with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalja Eigėlienė more than expected).
Fields of papers citing papers by Natalja Eigėlienė
This network shows the impact of papers produced by Natalja Eigėlienė. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalja Eigėlienė. The network helps show where Natalja Eigėlienė may publish in the future.
Co-authors
The 24 scholars most cited alongside Natalja Eigėlienė, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study Hit paper breakdown → | 2021 | 275 |
| 2 | 2019 | 64 | |
| 3 | 2019 | 17 | |
| 4 | 2021 | 14 | |
| 5 | 2020 | 13 | |
| 6 | 2014 | 12 | |
| 7 | 2017 | 10 | |
| 8 | 2020 | 10 | |
| 9 | 2022 | 10 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 0 |
About Natalja Eigėlienė
Natalja Eigėlienė is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Pharmacology and Pathology and Forensic Medicine, having authored 13 papers that have together received 434 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Colorectal Cancer Surgical Treatments (1 paper), Mechanisms of cancer metastasis (1 paper), Breast Lesions and Carcinomas (1 paper) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Cancer Research (185 citations), Pulmonary and Respiratory Medicine (165 citations), Oncology (39 citations), Pharmacology (14 citations) and Radiology, Nuclear Medicine and Imaging (22 citations). Natalja Eigėlienė has collaborated with scholars based in Finland, Sweden and Germany. Frequent co-authors include Antti Pekka Jekunen, Jatta Saarenheimo, Heidi Andersén, Marja Annika Tiirola, Pirkko L. Härkönen, Gajja Sophi Salomons, Raymon Vijzelaar, André B. P. Kuilenburg, Kalervo Väänänen and Jenni E. Keskitalo. Their work appears in journals such as Frontiers in Oncology, Cancer Chemotherapy and Pharmacology, Annals of Oncology, Radiation Oncology and Hormone and Metabolic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.